Leaderboard

En | De
Sie sind hier: Gastroenterologie » Leber » Neoplasie 02. Mai 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Hepatitis
Leberzirrhose
Neoplasie
Portale Hypertonie
Anderes
Magen-Darm
Oesophagus
Pankreas
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 3799  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 75964  
   
Navigating the Tumor Microenvironment in Colorectal Liver Metastasis: Barriers to Therapy and Emerging Opportunities.
Oncol Res
Hu P, Sun J, Lu J, Ge C, Sun H, Lv C.
PMID: 42065073 [PubMed - indexed for MEDLINE]


Navigating the Labyrinth of Hepatocellular Carcinoma: Leveraging AI/ML for Precision Oncology.
Oncol Res
Manan A, Ilyas S.
PMID: 42065059 [PubMed - indexed for MEDLINE]


Machine Learning (ML) and Molecular Dynamics-Driven Optimization of VEGFR2 Ligands against Hepatocellular Carcinoma.
Oncol Res
Yasmeen F, Manan A, Kim W, Choi S.
PMID: 42065051 [PubMed - indexed for MEDLINE]


ACSL4 as a context-dependent metabolic switch in hepatocellular carcinoma: implications for ferroptosis and immunotherapy.
Front Immunol
Luo Q, Zhang Z.
PMID: 42064086 [PubMed - indexed for MEDLINE]


Drug resistance mechanisms of immunotherapy and translational strategies for reversing resistance for hepatocellular carcinoma: from bench to bedside.
Front Immunol
Zhang C, Zhang D, Wen X, Liu S.
PMID: 42064051 [PubMed - indexed for MEDLINE]


Radiologic Response Assessment With RECIST 1.1 and mRECIST in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.
Korean J Radiol
Jeong B, Park HJ, Choi WM, Choi SH, Kim KW, Kim SY, Lee SS.
PMID: 42062227 [PubMed - indexed for MEDLINE]


International multisociety Delphi consensus for liver tumour thermal ablation: procedural and practice standards.
Lancet Oncol
Laimer G, Johnston EW, Overduin CG, Paolucci I, Ahmed M, Arellano RS, Beermann M, Beyer LP, Breen DJ, Burgmans MC, Calandri M, Chern MC, Crocetti L, van Dam RM, Denys A, Edwin B, Filippiadis D, Fong Y, Fotiadis N, Freedman J, Fretland ÅA, Gimenez M, Garcia RG, Grasso RF, Helmberger TK, Hendriks P, Iezzi R, Jenniskens SF, Kupferthaler A, Lachenmayer A, Lee FT Jr, Lee JM, van der Lei S, van der Leij C, Liang P, Lin CC, Luerken L, Maglione M, Mahnken A, McWilliams JP, Menezes M, Narayanan G, Orsi F, Pereira PL, Pua U, Puijk RS, Rhim H, Rilling WS, Ruiter SJS, Ryan AG, Schullian P, Shyn PB, Siriwardena AK, Smits MLJ, Sofocleous CT, Solbiati L, Sotirchos V, Stättner S, van Strijen M, Syversveen T, Tinguely P, Tselikas L, Vauthey JN, Vogl TJ, Wah TM, White SB, Wiggermann P, Wood BJ, van der Meulen J, Goldberg SN, Meijerink MR, Odisio BC, Bale R.
PMID: 42061383 [PubMed - indexed for MEDLINE]


International multisociety Delphi consensus for liver tumour thermal ablation: margin assessment.
Lancet Oncol
Paolucci I, Overduin CG, Johnston EW, Laimer G, Ahmed M, Arellano RS, Beerman M, Beyer LP, Breen DJ, Burgmans MC, Calandri M, Chern MC, Crocetti L, van Dam RM, Denys A, Edwin B, Filippiadis D, Fong Y, Fotiadis N, Freedman J, Fretland ÅA, Gimenez M, Garcia RG, Grasso RF, Helmberger TK, Hendriks P, Iezzi R, Jenniskens SF, Kupferthaler A, Lachenmayer A, Lee FT Jr, Lee JM, van der Lei S, van der Leij C, Liang P, Lin CC, Luerken L, Maglione M, Mahnken A, McWilliams JP, Menezes M, Narayanan G, Orsi F, Pereira PL, Pua U, Puijk RS, Rhim H, Rilling WS, Ruiter SJS, Ryan AG, Schullian P, Shyn PB, Siriwardena AK, Smits MLJ, Sofocleous CT, Solbiati L, Sotirchos V, Stättner S, van Strijen M, Syversveen T, Tinguely P, Tselikas L, Vauthey JN, Vogl TJ, Wah TM, White SB, Wiggermann P, Wood BJ, van der Meulen J, Goldberg SN, Meijerink MR, Bale R, Odisio BC.
PMID: 42061382 [PubMed - indexed for MEDLINE]


Hepatosplenic T-cell Lymphoma Masquerading as Idiopathic Cytopenia.
Malays J Pathol
Raghvan HP, Wee SY, Liam CCK, Mohd Shakri N, Ho CSL, Jamian E, Subbiah I, Khalid N.
PMID: 42059175 [PubMed - indexed for MEDLINE]


Macrophage-related Genomic Signatures Predict HCC Prognosis and Therapy Response.
Cancer Genomics Proteomics
Zhong W, Duan L, Zhang F, Zou C, Qiu J, Hu S, Yu M, Yin ZI.
PMID: 42055628 [PubMed - indexed for MEDLINE]


Multifunctional double hairpin DNA polydopamine nano-system for "switch-on" detection and intervention of high-grade dysplastic nodules.
Mikrochim Acta
Zhou J, Feng J, Dong X, Zhang T, Wei Y, Wang Y, Shi C.
PMID: 42053823 [PubMed - indexed for MEDLINE]


Beyond silencing: integrative multi-omics and spatial profiling unravel the systems-level role of piRNAs in HBV-driven Hepatocarcinogenesis.
Mol Biol Rep
Zainb A, Altalbawy FMA, Younis SMD, Ali Al-Bazi SM, Eiada AA, Zain Al-Abdeen SH, Norberdiyeva M, Smerat A.
PMID: 42053692 [PubMed - indexed for MEDLINE]


Overcoming immune resistance in hepatocellular carcinoma: insights into mechanisms, predictive factors, and interventional strategies.
Front Immunol
Wang Z, Wu J, Li Q, Wen X.
PMID: 42051530 [PubMed - indexed for MEDLINE]


Durable response to FOLFOX plus serplulimab in AFP-producing gastric adenocarcinoma with liver metastases: a case report and literature review.
Front Immunol
Jin Y, Fu L, Zhao Y, Tong Z, Tan Y.
PMID: 42051505 [PubMed - indexed for MEDLINE]


Is PD-1/PD-L1 inhibitor plus bevacizumab superior to sorafenib as first-line treatment for advanced hepatocellular carcinoma? A pooled analysis of four phase 3 RCTs.
BMC Gastroenterol
Zhong Q, Li H, Hu W, Li Z, Hu Z.
PMID: 42050438 [PubMed - indexed for MEDLINE]


New Pathological Insights into Biomarkers for Multimodal Therapeutic Approach in Hepatic Neuroendocrine Tumors: A Detailed Case Report.
In Vivo
Tsai YC, Lin CH, Hung CH, Ou JJ, Lee YT.
PMID: 42049452 [PubMed - indexed for MEDLINE]


Identification of Risk Factors for the Local Recurrence of Hepatocellular Carcinoma Post-radiofrequency Ablation.
Anticancer Res
Tanaka K, Kuwano A, Yada M, Suzuki H, Motomura K.
PMID: 42049332 [PubMed - indexed for MEDLINE]


AdvanTIG-206: a phase II, randomized study of ociperlimab plus tislelizumab and BAT1706 (bevacizumab biosimilar) versus tislelizumab and BAT1706 in first-line hepatocellular carcinoma.
Cancer Immunol Immunother
Ren Z, Huang Y, Guo Y, Hou MM, Wang W, Kuang M, Hao C, Wang W, Zhang Y, Song T, Dai C, Kuo HT, Bao Z, Zuo Y, Wang L, Zhu F, Fan J.
PMID: 42047833 [PubMed - indexed for MEDLINE]


CEUS-Based Microvascular Invasion Predictor in HCC: Improving Prognostic Stratification Following Thermal Ablation.
Liver Int
Chen K, Zhang S, Huang T, Xu Y, Zhang Q, Zhu Y, Wan P, Kong W, Wang W.
PMID: 42047408 [PubMed - indexed for MEDLINE]


Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Chinese Retrospective Multicenter Study Based on Global Meta-Analysis.
Cancer Med
Xu J, Zhang YL, Yang M, Deng Z, Li L, Wang T, Song J, Xu H, Wu J, Wu ZQ, Xu HG.
PMID: 42047297 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 75964    Seite 1 von 3799  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1